Press Releases CalciMedica, Inc.

Equities

CALC

US38942Q2021

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
5.2 ^USD	-7.14%		-7.80%	+81.81%

Apr. 24	Calcimedica Inc. Announces Last Patient Enrolled in Phase 2B Carpo Trial of Auxora? in Acute Pancreatitis	CI
Apr. 01	Top Premarket Decliners	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates	May. 13	PR
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis	Apr. 25	AQ
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis	Apr. 24	PR
CalciMedica : Material Event - Form 8-K	Mar. 29	PU
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference	Mar. 13	PR
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI and CRRT Conference	Feb. 29	AQ
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference	Feb. 28	PR
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury	Feb. 14	AQ
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury	Feb. 13	PR
CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 07	PR
CalciMedica Announces Private Placement of up to Approximately $55 Million	Jan. 22	PR
CalciMedica Announces Upcoming Presentations and Events in September	23-09-06	PR
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023	23-08-31	PR
CalciMedica : BUSINESS SECTION - Form 8-K	23-08-11	PU
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates	23-08-10	GL
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)	23-08-09	GL
CalciMedica : Shareholder Director Nominations - Form 8-K	23-06-27	PU
CALCIMEDICA, INC. Financial Statements and Exhibits (form 8-K/A)	23-04-04	AQ
CALCIMEDICA, INC. /DE/ : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-22	AQ
CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement	23-03-20	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CalciMedica, Inc.

Equities

CALC

US38942Q2021

Press Releases

Filters